pyrimethamine has been researched along with Congenital Infection, Toxoplasma gondii in 184 studies
Maloprim: contains above 2 cpds
Excerpt | Relevance | Reference |
---|---|---|
"This was a randomized, open-label trial in 36 French centers, comparing pyrimethamine (50 mg qd) + sulfadiazine (1 g tid) with folinic acid vs spiramycin (1 g tid) following toxoplasmosis seroconversion." | 9.27 | Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. ( Berrebi, A; Biquard, F; Bory, JP; Cordier, AG; d'Ercole, C; Houfflin-Debarge, V; Jouannic, JM; Kieffer, F; Laurichesse-Delmas, H; Le Bouar, G; Mandelbrot, L; Mesnard, L; Perrotin, F; Sitta, R; Thiébaut, R; Ville, Y; Villena, I; Winer, N, 2018) |
"To compare the effectiviness of spiramycin/cotrimoxazole (Sp/C) versus pyrimethamine/sulfonamide (Pyr/Sul) and spiramycin alone (Spy) on mother-to-child transmission of toxoplasmosis infection in pregnancy." | 7.81 | Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy. ( Barone, G; Buonsenso, D; Calzedda, R; Ceccarelli, M; Masini, L; Ricci, R; Serranti, D; Speziale, D; Valentini, P, 2015) |
"This was a randomized, open-label trial in 36 French centers, comparing pyrimethamine (50 mg qd) + sulfadiazine (1 g tid) with folinic acid vs spiramycin (1 g tid) following toxoplasmosis seroconversion." | 5.27 | Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. ( Berrebi, A; Biquard, F; Bory, JP; Cordier, AG; d'Ercole, C; Houfflin-Debarge, V; Jouannic, JM; Kieffer, F; Laurichesse-Delmas, H; Le Bouar, G; Mandelbrot, L; Mesnard, L; Perrotin, F; Sitta, R; Thiébaut, R; Ville, Y; Villena, I; Winer, N, 2018) |
"The aim was to evaluate the safety profile of pyrimethamine-based treatment for the three main Toxoplasma manifestations: toxoplasmic encephalitis (TE), ocular toxoplasmosis, and congenital toxoplasmosis." | 4.95 | Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review. ( Ben-Harari, RR; Casoy, J; Goodwin, E, 2017) |
"To compare the effectiviness of spiramycin/cotrimoxazole (Sp/C) versus pyrimethamine/sulfonamide (Pyr/Sul) and spiramycin alone (Spy) on mother-to-child transmission of toxoplasmosis infection in pregnancy." | 3.81 | Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy. ( Barone, G; Buonsenso, D; Calzedda, R; Ceccarelli, M; Masini, L; Ricci, R; Serranti, D; Speziale, D; Valentini, P, 2015) |
"We reviewed the series of cases published in the English literature on antiparasitic treatment of acute toxoplasmosis infection in pregnancy, using spiramycin until fetal infection is documented, then using cycles of spiramycin alternated with combined pyrimethamine-sulfonamide therapy." | 3.70 | Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone. ( Ceruti, P; Ghidini, A; Rescaldani, R; Spelta, A; Strobelt, N; Vergani, P; Zapparoli, B, 1998) |
" In case of maternal contamination after 33 weeks of pregnancy, pyrimethamine-sulfadiazine combination should be used in spite of its potential toxicity." | 3.67 | New perspectives in the chemoprophylaxis of toxoplasmosis. ( Garin, JP; Piens, MA, 1989) |
"Prenatal diagnosis of congenital toxoplasmosis is based on a combination of examinations: PCR testing for the parasite in amniotic fluid, mouse inoculation, fetal ultrasonography, and magnetic resonance imaging." | 2.46 | [Management of congenital toxoplasmosis in France: current data]. ( Dumon, H; Franck, J; Garcia-Méric, P; Piarroux, R, 2010) |
"Postpartum treatment of congenital toxoplasmosis with sulfadiazine and pyrimethamine has remained almost unchanged for 50 years." | 2.42 | Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? ( Petersen, E; Schmidt, DR, 2003) |
"To summarise the evidence that treating toxoplasmosis in pregnancy reduces the risk of congenital toxoplasma infection and improves infant outcomes." | 2.40 | Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. ( Garner, P; Liou, C; Peyron, F; Wallon, M, 1999) |
"In general, prenatal therapy of congenital toxoplasmosis is beneficial in reducing the frequency of infant infection." | 2.39 | Management of toxoplasmosis. ( Georgiev, VS, 1994) |
"Ocular toxoplasmosis is a frequent cause of ocular inflammation which threatens central visual acuity." | 2.38 | [Treatment of ocular toxoplasmosis. Part 1: Basic principles and diagnosis]. ( Mittelviefhaus, H, 1993) |
"Preventing congenital toxoplasmosis is fundamental, and in France screening tests for primary infection are obligatory for pregnant women." | 2.38 | [Prevention and treatment of materno-fetal toxoplasmosis]. ( Aissi, E; Ajana, F; Camus, D; Fortier, B; Pinto de Sousa, MI, 1991) |
"Twenty-nine infants (15." | 1.62 | Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak. ( Belfort, R; Belucik, DN; Commodaro, AG; Conceição, AR; Costa, DF; de Oliveira Dias, JR; Gustavo Brenner, L; Henrique Monteiro, M; Missio, L; Ribeiro, KS; Valadão, MCDS, 2021) |
"Twenty newborns had congenital toxoplasmosis: 19 cases were diagnosed by serology and one case was diagnosed after amniocentesis." | 1.48 | [Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia]. ( Aoun, K; Ben Abdallah, R; Bouhlel, S; Bouratbine, A; Maatoug, R; Souissi, O, 2018) |
"We conclude that this is a rare case of anophthalmia combined with craniofacial cleft due to congenital toxoplasmosis, that must be considered by physicians." | 1.46 | Report of an unsual case of anophthalmia and craniofacial cleft in a newborn with Toxoplasma gondii congenital infection. ( Arce-Estrada, GE; Bosch-Canto, V; Cedillo-Peláez, C; Correa, D; Gómez-Toscano, V; Mayorga-Butrón, JL; Sesman-Bernal, AL; Vargas-Villavicencio, JA, 2017) |
" In most cases, it was not severe and reversed after increase in folinic acid dosage (25." | 1.46 | High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil. ( Carellos, EVM; de Andrade, GMQ; de Andrade, JQ; Figueiredo, RM; Januário, JN; Romanelli, RMC; Tibúrcio, JD; Vasconcelos-Santos, DV, 2017) |
"8%) presented at least 1 adverse clinical event that was nonspecific, such as diarrhea on the day of drug administration, vomiting and agitation." | 1.43 | Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment. ( Charpiat, B; Corvaisier, S; Dupont, D; Leboucher, G; Peyron, F; Teil, J; Vial, T; Wallon, M, 2016) |
"Question Congenital toxoplasmosis is a dangerous fetal infection." | 1.40 | Toxoplasmosis and pregnancy. ( Chaudhry, SA; Gad, N; Koren, G, 2014) |
"The birth prevalence of congenital toxoplasmosis is high in the Brazilian state of Sergipe, with most of the infants showing ocular lesions." | 1.38 | Birth prevalence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil. ( Araújo, RM; Carvalheiro, CG; Cipolotti, R; de Melo Inagaki, AD; Gurgel, RQ; Lima, DR; Mussi-Pinhata, MM; Pinheiro, KS; Rocha, DA; Winandy, JL, 2012) |
"We report a case of congenital toxoplasmosis following infection occurring late in pregnancy." | 1.37 | [Congenital toxoplasmosis following infection occurring late in pregnancy]. ( Aoun, K; Ben Abdallah, R; Bouratbine, A; Maatoug, R; Siala, E; Souissi, O, 2011) |
"Pyrimethamine was used in a single daily dose at an amount of 0." | 1.37 | Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations. ( Filipek, M; Lipka, B; Milewska-Bobula, B, 2011) |
"He had partial seizures 48 h after the last medicinal absorption." | 1.37 | [Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?]. ( de Montgolfier, I; Freihuber, C; Genuini, M; Girard, I; Kieffer, F; Mitanchez, D, 2011) |
"However, neither the prevalence of congenital toxoplasmosis (CT) nor the confirmed case to CT is reported from Nepal yet." | 1.37 | First case of congenital toxoplasmosis from Nepal. ( Pradhan, P; Rai, SK; Sharma, A; Shrestha, RK, 2011) |
"Currently, there is no ideal drug for congenital toxoplasmosis; future research should focus on the screening of new active drugs and on their pre-clinical and early clinical development, with a focus on pharmacokinetic/dynamic studies and teratogenicity." | 1.35 | Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis. ( Chêne, G; Thiébaut, R, 2009) |
"Retinochoroiditis is the main complication of congenital toxoplasmosis." | 1.35 | Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. ( Franck, J; Garcia, P; Kieffer, F; Peyron, F; Thulliez, P; Wallon, M, 2008) |
"Fourteen cataracts were present at birth and 13 developed postnatally." | 1.34 | Cataracts in congenital toxoplasmosis. ( Alam, A; Arun, V; Boyer, K; Cezar, S; Del Monte, MA; Greenwald, MJ; Jalbrzikowski, J; Karrison, T; Kasza, K; Latkany, P; McLeod, R; Mets, MB; Mieler, W; Noble, AG; Rabiah, P; Roizen, N; Sautter, M; Swisher, CN; Troia, RN, 2007) |
"Without treatment, congenital toxoplasmosis has recurrent, recrudescent, adverse outcomes." | 1.33 | Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. ( Boyer, K; Heydemann, P; Holfels, E; Jalbrzikowski, J; Karrison, T; Kasza, K; Latkany, P; McLeod, R; Meier, P; Mets, M; Noble, AG; Remington, J; Roizen, N; Swisher, C; Withers, S, 2006) |
"Pyrimethamine was found to give a linear response using MS detection in the range 0." | 1.33 | Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis. ( Christiansen, I; Hansen, SH; Johannessen, JK; Petersen, E; Schmidt, DR, 2005) |
"The overall functional prognosis of congenital toxoplasmosis is better than would be expected on the basis of literature findings, with only 2 of the 130 children suffering bilateral visual impairment." | 1.33 | Ocular manifestations in congenital toxoplasmosis. ( Binquet, C; Denis, P; Fleury, J; Garweg, JG; Kodjikian, L; Peyron, F; Wallon, M, 2006) |
"Pyrimethamine-sulfonamides treatment was continued from birth to 1 year of age." | 1.32 | Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. ( Brézin, AP; Couvreur, J; Mcleod, R; Mets, MB; Nobré, R; Thulliez, P, 2003) |
" To optimize PYR/SDX combination treatment in congenital toxoplasmosis, short dosing intervals in very young low-wight children are probably appropriate." | 1.32 | Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis. ( Chemla, C; Dupouy, D; Jaussaud, R; Leroux, B; Millart, H; Pinon, JM; Quereux, C; Rémy, G; Simon, N; Trenque, T; Urien, S; Villena, I, 2004) |
"To present a case of congenital toxoplasmosis in a newborn whose mother had a 20-year history of a chorioretinal macular scar and positive serology for toxoplasmosis." | 1.32 | Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. ( Belfort, R; Ferreira, R; Muccioli, C; Nussenblatt, R; Silveira, C, 2003) |
"The treatment of reference of congenital toxoplasmosis combines two folate synthesis inhibitors, pyrimethamine and an antibacterial sulfamide (sulfadiazine or sulfadoxine)." | 1.32 | [Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis]. ( Coutty, N; Decocq, J; Delahousse, G; Detourmignies, L; Le Goueff, F; Mubiayi, N, 2004) |
"Congenital toxoplasmosis is a potentially serious infection which usually affects infants born to non immune women." | 1.32 | [Congenital toxoplasmosis: a new case of infection during pregnancy in an previously immunized and immunocompetent woman]. ( Baudon, JJ; Ducrocq, S; Gold, F; Lebas, F; Mégier, P; Mucignat, V; Paris, L, 2004) |
"Toxoplasmosis was detected in those persons having lymphadenitis, therapeutical patients, women with aggravated obstetrical history having had spontaneous abortions and having given birth to sick children, patients with sluggish meningoencephalitis presenting with epileptoid and hypothalamic syndrome, polyneuritis, and patients with myopia, chorioretinitis and uveitis." | 1.31 | [Toxoplasmosis in sick persons]. ( Netrebko, ID, 2002) |
"Fifty-seven cases of congenital toxoplasmosis were demonstrated (34." | 1.31 | Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. ( Berrebi, A; Bessières, MH; Bloom, MC; Cassaing, S; Courjault, C; Rolland, M; Roques, C; Séguéla, JP, 2001) |
"Our current treatment strategy for congenital toxoplasmosis consists of a 24-month course of pyrimethamine-sulfadoxine (Fansidar) combined with folinic acid (Lederfoline)." | 1.30 | Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. ( Aubert, D; Bonhomme, A; Chemla, C; Dupouy, D; Guenounou, M; Leroux, B; Pinon, JM; Pluot, M; Quereux, C; Schmit, G; Talmud, M; Trenque, T; Villena, I, 1998) |
"We report a female patient with congenital toxoplasmosis who presented with hydrops fetalis and cerebral abnormalities, detected on fetal ultrasound." | 1.30 | Congenital toxoplasmosis: prenatal diagnosis, treatment and postnatal outcome. ( Blaser, S; Chitayat, D; Ford-Jones, LE; Friedman, S; Ryan, G; Toi, A, 1999) |
"We report two cases of congenital toxoplasmosis following maternal primary infection occurring late during pregnancy." | 1.30 | [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy]. ( Botterel, F; Bourée, P; Ithier, G; Romand, S; Wirden, M, 1999) |
"Many children with congenital toxoplasmosis have substantial retinal damage at birth and consequent loss of vision." | 1.30 | Eye manifestations of congenital toxoplasmosis. ( Boyer, KM; Holfels, E; Hopkins, J; Luciano, R; Mack, D; McLeod, R; Meier, P; Mets, MB; Patel, D; Remington, JS; Roizen, N; Stein, L; Stein, M; Swisher, CN; Withers, S, 1997) |
"To describe a case of severe congenital toxoplasmosis because of inadequate surveillance of a seronegative pregnant woman and to evaluate the usefulness of different microbiological diagnostic methods after birth." | 1.30 | [Analysis of a case of severe congenital toxoplasmosis]. ( Coll, O; Costa, J; Falgueras, T; Gómez-López, L; Pujol-Riqué, M; Rodríguez-Miguélez, JM; Tudó, G; Valls, ME, 1999) |
"Seventeen of 18 children without hydrocephalus and six of eight children with obstructive hydrocephalus responsive to shunting had normal or near-normal neurologic and developmental outcomes." | 1.29 | Neurologic and developmental outcome in treated congenital toxoplasmosis. ( Boyer, KM; Holfels, E; Hopkins, J; Meier, P; Mets, MB; Patel, D; Roizen, N; Stein, L; Stein, MA; Swisher, CN, 1995) |
"Most infants with congenital Toxoplasma gondii infection have no symptoms at birth, but many will have retinal disease or neurologic abnormalities later in life." | 1.29 | Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. ( Abroms, I; Eaton, RB; Guerina, NG; Hoff, R; Hsu, HW; Lynfield, R; Maguire, JH; Meissner, HC; Pasternack, MS; Stechenberg, B, 1994) |
"We describe the case of a patient with systemic lupus erythematosus, treated by corticosteroids, who presented during two successive pregnancies with serological reactivation of toxoplasmosis associated with fetal lesions." | 1.29 | Recurrent congenital toxoplasmosis in a woman with lupus erythematosus. ( Blanc, B; Boubli, L; Casta, M; Chagnon, C; Cravello, L; D'Ercole, C; Franck, J; Harle, JR; Leclaire, M, 1995) |
"There were recurrences in both treated (13%, 7/54) and previously untreated historical patients (44%, 8/18)." | 1.29 | Eye manifestations of congenital toxoplasmosis. ( Boyer, KM; Holfels, E; Hopkins, J; Luciano, R; Mack, D; McLeod, R; Meier, P; Mets, MB; Patel, D; Remington, JS; Roizen, N; Stein, L; Stein, M; Swisher, CN; Withers, S, 1996) |
"Twenty-six cases of congenital toxoplasmosis observed in the department of Alpes Maritimes (Chief Town: Nice) between 1984 and 1990 are reported." | 1.28 | [Congenital toxoplasmosis in the Alpes-Maritimes region. Apropos of 26 cases observed between 1984 and 1990]. ( Deville, A; Ferret, N; Le Fichoux, Y; Mariani, R; Marty, P; Tommasi, C; Tordjman, C; Velin, P, 1992) |
"Incidence of congenital toxoplasmosis varies from 0." | 1.28 | [Prevention of congenital toxoplasmosis]. ( Galanti, B; Russo, M, 1990) |
"Two newborn infants with congenital toxoplasmosis despite serological testing during pregnancy were observed at our premature and neonatal intensive care unit within a short time of one another." | 1.26 | [Congenital toxoplasmosis in two newborn infants (author's transl)]. ( Coradello, H; Lubec, G; Simbruner, G, 1981) |
"Even simple lymphadenitis during pregnancy may possibly be an acquired lymphatic form of toxoplasmosis with all detrimental consequences to the foetus." | 1.26 | [Lymphadenitis caused by toxoplasmosis during gravidity -- an aetiological factor in congenital damage to the child (author's transl)]. ( Kouba, K; Lasovská, J; Moravcová, E, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 75 (40.76) | 18.7374 |
1990's | 40 (21.74) | 18.2507 |
2000's | 38 (20.65) | 29.6817 |
2010's | 30 (16.30) | 24.3611 |
2020's | 1 (0.54) | 2.80 |
Authors | Studies |
---|---|
Portes, JA | 1 |
De Souza, W | 1 |
Conceição, AR | 1 |
Belucik, DN | 1 |
Missio, L | 1 |
Gustavo Brenner, L | 1 |
Henrique Monteiro, M | 1 |
Ribeiro, KS | 1 |
Costa, DF | 1 |
Valadão, MCDS | 1 |
Commodaro, AG | 1 |
de Oliveira Dias, JR | 1 |
Belfort, R | 2 |
Arce-Estrada, GE | 1 |
Gómez-Toscano, V | 1 |
Cedillo-Peláez, C | 1 |
Sesman-Bernal, AL | 1 |
Bosch-Canto, V | 1 |
Mayorga-Butrón, JL | 1 |
Vargas-Villavicencio, JA | 1 |
Correa, D | 1 |
Rioualen, S | 1 |
Dufau, J | 1 |
Flatres, C | 1 |
Lavenant, P | 1 |
Misery, L | 1 |
Roué, JM | 1 |
Ben-Harari, RR | 1 |
Goodwin, E | 1 |
Casoy, J | 1 |
Loveridge-Easther, C | 1 |
Yardley, AM | 1 |
Breidenstein, B | 1 |
Boudaouara, Y | 1 |
Aoun, K | 3 |
Maatoug, R | 3 |
Souissi, O | 3 |
Bouratbine, A | 3 |
Abdallah, RB | 1 |
Mandelbrot, L | 1 |
Kieffer, F | 4 |
Sitta, R | 1 |
Laurichesse-Delmas, H | 1 |
Winer, N | 1 |
Mesnard, L | 1 |
Berrebi, A | 5 |
Le Bouar, G | 1 |
Bory, JP | 1 |
Cordier, AG | 1 |
Ville, Y | 1 |
Perrotin, F | 2 |
Jouannic, JM | 1 |
Biquard, F | 1 |
d'Ercole, C | 2 |
Houfflin-Debarge, V | 1 |
Villena, I | 8 |
Thiébaut, R | 2 |
Bouhlel, S | 1 |
Ben Abdallah, R | 2 |
Silva, LA | 1 |
Fernandes, MD | 1 |
Machado, AS | 1 |
Reis-Cunha, JL | 1 |
Bartholomeu, DC | 1 |
Almeida Vitor, RW | 1 |
Kravetz, J | 1 |
Chaudhry, SA | 1 |
Gad, N | 1 |
Koren, G | 1 |
Valentini, P | 1 |
Buonsenso, D | 1 |
Barone, G | 1 |
Serranti, D | 1 |
Calzedda, R | 1 |
Ceccarelli, M | 1 |
Speziale, D | 1 |
Ricci, R | 1 |
Masini, L | 1 |
Teil, J | 1 |
Dupont, D | 2 |
Charpiat, B | 1 |
Corvaisier, S | 1 |
Vial, T | 1 |
Leboucher, G | 1 |
Wallon, M | 7 |
Peyron, F | 6 |
Carellos, EVM | 1 |
de Andrade, JQ | 1 |
Romanelli, RMC | 1 |
Tibúrcio, JD | 1 |
Januário, JN | 1 |
Vasconcelos-Santos, DV | 1 |
Figueiredo, RM | 1 |
de Andrade, GMQ | 1 |
Chemla, C | 5 |
Guha, R | 1 |
Miley, L | 1 |
Aspiri, M | 1 |
Dhamija, R | 1 |
Chêne, G | 1 |
Bessières, MH | 4 |
Cassaing, S | 4 |
Fillaux, J | 1 |
Cambus, JP | 1 |
Berry, A | 1 |
Assouline, C | 3 |
Ayoubi, JM | 2 |
Magnaval, JF | 1 |
Costa, IN | 1 |
Angeloni, MB | 1 |
Santana, LA | 1 |
Barbosa, BF | 1 |
Silva, MC | 1 |
Rodrigues, AA | 1 |
Rostkowsa, C | 1 |
Magalhães, PM | 1 |
Pena, JD | 1 |
Silva, DA | 1 |
Mineo, JR | 1 |
Ferro, EA | 1 |
Garcia-Méric, P | 1 |
Franck, J | 4 |
Dumon, H | 1 |
Piarroux, R | 1 |
Al-Hamod, D | 1 |
Vauloup, C | 1 |
Goulet, M | 1 |
Zupan-Simunek, V | 1 |
Castel, C | 1 |
Boileau, P | 1 |
Röser, D | 1 |
Nielsen, HV | 1 |
Petersen, E | 5 |
Saugmann-Jensen, P | 1 |
Nørgaard-Pedersen, B | 1 |
Nørgaard-Pedersen, PB | 1 |
Lathière, M | 1 |
Minville, V | 1 |
Mavrikakis, E | 1 |
Levin, AV | 1 |
Lam, WC | 1 |
Ajzenberg, D | 1 |
Siala, E | 1 |
Lipka, B | 1 |
Milewska-Bobula, B | 1 |
Filipek, M | 1 |
Genuini, M | 1 |
Freihuber, C | 1 |
Girard, I | 1 |
de Montgolfier, I | 1 |
Mitanchez, D | 1 |
Rai, SK | 1 |
Sharma, A | 1 |
Shrestha, RK | 1 |
Pradhan, P | 1 |
Pohl-Schickinger, A | 1 |
Feiterna-Sperling, C | 1 |
Weizsäcker, K | 1 |
Bührer, C | 1 |
Chuang, YC | 1 |
Chen, JY | 1 |
Ji, DD | 1 |
Su, PH | 1 |
de Melo Inagaki, AD | 1 |
Carvalheiro, CG | 1 |
Cipolotti, R | 1 |
Gurgel, RQ | 1 |
Rocha, DA | 1 |
Pinheiro, KS | 1 |
Araújo, RM | 1 |
Lima, DR | 1 |
Winandy, JL | 1 |
Mussi-Pinhata, MM | 1 |
Gaucherand, P | 1 |
Al Kurdi, M | 1 |
Hill, D | 1 |
Dubey, JP | 1 |
Netrebko, ID | 1 |
Maeda, T | 1 |
Brézin, AP | 1 |
Thulliez, P | 6 |
Couvreur, J | 8 |
Nobré, R | 3 |
Mcleod, R | 9 |
Mets, MB | 6 |
Foulon, W | 2 |
Silveira, C | 1 |
Ferreira, R | 1 |
Muccioli, C | 1 |
Nussenblatt, R | 1 |
Brady-McCreery, KM | 1 |
Hussein, MA | 1 |
Paysse, EA | 1 |
ALEZZANDRINI, AA | 1 |
HERNANDEZ, R | 1 |
OCKLITZ, HW | 1 |
SCHMITZ, HH | 1 |
ZIESCHE, H | 1 |
GENZ, H | 1 |
MOHR, W | 2 |
PIEKARSKI, G | 2 |
WENZEL, B | 1 |
SICHERT, H | 1 |
GOLIAS-MAKOWSKA, A | 1 |
REMINGTON, JS | 6 |
HICKL, EJ | 1 |
MOHR, U | 1 |
MARTIUS, G | 1 |
PULLON, DH | 1 |
Christoph, J | 1 |
Kattner, E | 1 |
Seitz, HM | 1 |
Reiter-Owona, I | 1 |
Trenque, T | 3 |
Simon, N | 1 |
Quereux, C | 3 |
Leroux, B | 3 |
Jaussaud, R | 1 |
Rémy, G | 1 |
Dupouy, D | 3 |
Millart, H | 1 |
Pinon, JM | 6 |
Urien, S | 1 |
Lebas, F | 1 |
Ducrocq, S | 1 |
Mucignat, V | 1 |
Paris, L | 1 |
Mégier, P | 1 |
Baudon, JJ | 1 |
Gold, F | 1 |
Schmidt, DR | 3 |
Mubiayi, N | 1 |
Coutty, N | 1 |
Detourmignies, L | 1 |
Le Goueff, F | 1 |
Decocq, J | 1 |
Delahousse, G | 1 |
Johannessen, JK | 1 |
Christiansen, I | 1 |
Hansen, SH | 2 |
Kodjikian, L | 1 |
Fleury, J | 1 |
Denis, P | 1 |
Binquet, C | 1 |
Garweg, JG | 1 |
Bachmeyer, C | 1 |
Mouchnino, G | 1 |
Blum, L | 1 |
Hogh, B | 1 |
Andersen, O | 1 |
Dalhoff, K | 1 |
Di Carlo, P | 2 |
Mazzola, A | 2 |
Romano, A | 2 |
Schimmenti, MG | 2 |
Colicchia, P | 1 |
Bellipanni, P | 1 |
Titone, L | 2 |
Gras, L | 1 |
Pollak, A | 2 |
Cortina-Borja, M | 1 |
Evengard, B | 1 |
Hayde, M | 2 |
Gilbert, R | 1 |
Boyer, K | 6 |
Karrison, T | 3 |
Kasza, K | 3 |
Swisher, C | 5 |
Roizen, N | 9 |
Jalbrzikowski, J | 3 |
Remington, J | 3 |
Heydemann, P | 1 |
Noble, AG | 3 |
Mets, M | 5 |
Holfels, E | 5 |
Withers, S | 5 |
Latkany, P | 3 |
Meier, P | 7 |
Altcheh, J | 1 |
Diaz, NS | 1 |
Pepe, CM | 1 |
Martin, V | 1 |
Nigro, M | 1 |
Freilij, H | 1 |
Angel, SO | 1 |
Bardou, M | 1 |
Nowakowska, D | 1 |
Castagno, R | 1 |
Rolland, M | 2 |
Bongain, A | 1 |
Monnier-Barbarino, P | 1 |
Casuccio, A | 1 |
Yuan, WY | 1 |
Wu, YP | 1 |
Geng, X | 1 |
Geng, DH | 1 |
Zhao, S | 1 |
Xue, J | 1 |
Fricker-Hidalgo, H | 2 |
Brenier-Pinchart, MP | 2 |
Schaal, JP | 1 |
Equy, V | 1 |
Bost-Bru, C | 2 |
Pelloux, H | 2 |
Phan, L | 1 |
Kuo, A | 1 |
Mieler, W | 2 |
Meyers, S | 2 |
Rabiah, P | 3 |
Cezar, S | 2 |
Arun, V | 1 |
Troia, RN | 1 |
Sautter, M | 1 |
Greenwald, MJ | 1 |
Alam, A | 1 |
Swisher, CN | 5 |
Del Monte, MA | 1 |
Garcia, P | 1 |
Thalhammer, O | 2 |
Whitley, RJ | 1 |
Alford, CA | 2 |
Maisonneuve, H | 1 |
Faber, C | 1 |
Piens, MA | 2 |
Garin, JP | 2 |
Desmonts, C | 1 |
van der Veen, J | 1 |
McCabe, RE | 1 |
Bonardi, R | 1 |
Morales Castillo, ME | 1 |
Cedillo Rivera, R | 1 |
Nottin, N | 1 |
Desmonts, G | 3 |
Coradello, H | 1 |
Lubec, G | 1 |
Simbruner, G | 1 |
Robinson, RO | 1 |
Baumann, RJ | 1 |
Georgiev, VS | 1 |
Krausse, T | 1 |
Straube, W | 1 |
Wiersbitzky, S | 1 |
Hitz, V | 1 |
Kewitsch, A | 1 |
Stein, MA | 2 |
Hopkins, J | 5 |
Boyer, KM | 5 |
Stein, L | 5 |
Patel, D | 6 |
Guerina, NG | 2 |
Hsu, HW | 1 |
Meissner, HC | 1 |
Maguire, JH | 1 |
Lynfield, R | 1 |
Stechenberg, B | 1 |
Abroms, I | 1 |
Pasternack, MS | 1 |
Hoff, R | 1 |
Eaton, RB | 1 |
McAuley, J | 1 |
Wolters, C | 1 |
Stein, M | 3 |
Schey, W | 1 |
Koskiniemi, M | 1 |
Wong, SY | 1 |
Mittelviefhaus, H | 1 |
Mirlesse, V | 1 |
Jacquemard, F | 1 |
Daffos, F | 2 |
Briese, V | 1 |
Rogmann, K | 1 |
Müller, H | 1 |
Plesse, R | 1 |
Patel, DV | 1 |
Holfels, EM | 1 |
Vogel, NP | 1 |
Roizen, NJ | 1 |
Stein, LK | 1 |
Withers, SE | 1 |
Mack, DG | 2 |
Luciano, RA | 1 |
McLeod, RL | 1 |
Boubli, L | 1 |
Casta, M | 1 |
Harle, JR | 1 |
Chagnon, C | 1 |
Cravello, L | 1 |
Leclaire, M | 1 |
Blanc, B | 1 |
Mack, D | 4 |
Luciano, R | 2 |
Cotty, F | 1 |
Carpentier, MA | 1 |
Descamps, P | 1 |
Richard-Lenoble, D | 1 |
Czarnecka-Rudnik, D | 1 |
Stanek-Bazylko, F | 1 |
Vergani, P | 1 |
Ghidini, A | 1 |
Ceruti, P | 1 |
Strobelt, N | 1 |
Spelta, A | 1 |
Zapparoli, B | 1 |
Rescaldani, R | 1 |
Aubert, D | 2 |
Talmud, M | 1 |
Schmit, G | 1 |
Guenounou, M | 1 |
Pluot, M | 1 |
Bonhomme, A | 1 |
Stray-Pedersen, B | 1 |
Decoster, A | 1 |
Lappalainen, M | 1 |
Jenum, PA | 1 |
Hedman, K | 1 |
Naessens, A | 1 |
Gratzl, R | 1 |
Kohlhauser, C | 1 |
Hermon, M | 1 |
Burda, G | 1 |
Strobl, W | 1 |
Friedman, S | 1 |
Ford-Jones, LE | 1 |
Toi, A | 1 |
Ryan, G | 1 |
Blaser, S | 1 |
Chitayat, D | 1 |
Liou, C | 1 |
Garner, P | 1 |
Koppe, JG | 2 |
Meenken, C | 1 |
Wirden, M | 1 |
Botterel, F | 1 |
Romand, S | 3 |
Ithier, G | 1 |
Bourée, P | 1 |
Djurkovic-Djakovic, O | 1 |
Pujol-Riqué, M | 1 |
Gómez-López, L | 1 |
Tudó, G | 1 |
Falgueras, T | 1 |
Costa, J | 1 |
Rodríguez-Miguélez, JM | 1 |
Coll, O | 1 |
Valls, ME | 1 |
Pfiffner, L | 1 |
Aitchison, V | 1 |
Bloom, MC | 1 |
Roques, C | 1 |
Courjault, C | 1 |
Séguéla, JP | 1 |
Brézin, A | 1 |
Yi-Gallimard, E | 1 |
Voyer, M | 1 |
Magny, JF | 1 |
Pons, JC | 1 |
Jouk, PS | 1 |
Ambroise-Thomas, P | 1 |
Matérnova, V | 1 |
Shevkunova, EA | 1 |
Kouba, K | 3 |
Lasovská, J | 1 |
Moravcová, E | 1 |
Miller, EC | 1 |
Kräubig, H | 1 |
Katz, D | 1 |
Apt, W | 1 |
Hengst, P | 2 |
Ferret, N | 1 |
Marty, P | 1 |
Tordjman, C | 1 |
Deville, A | 1 |
Tommasi, C | 1 |
Velin, P | 1 |
Mariani, R | 1 |
Le Fichoux, Y | 1 |
Foss, R | 1 |
Levin, S | 1 |
Hubbell, J | 1 |
Singh, S | 1 |
Fortier, B | 1 |
Ajana, F | 1 |
Pinto de Sousa, MI | 1 |
Aissi, E | 1 |
Camus, D | 1 |
Holliman, RE | 1 |
Johnson, JD | 1 |
Constantine, G | 1 |
Bissenden, JG | 1 |
Nicolaides, K | 1 |
Savva, D | 1 |
Boulot, P | 1 |
Pratlong, F | 1 |
Sarda, P | 1 |
Deschamps, F | 1 |
Hedon, B | 1 |
Laffargue, F | 1 |
Viala, JL | 1 |
Beckmann, E | 1 |
Vitullo, D | 1 |
Johnson, D | 1 |
Russo, M | 1 |
Galanti, B | 1 |
Wilson, CB | 2 |
Mitchell, CD | 1 |
Erlich, SS | 1 |
Mastrucci, MT | 1 |
Hutto, SC | 1 |
Parks, WP | 1 |
Scott, GB | 1 |
Hohlfeld, P | 1 |
Aufrant, C | 1 |
MacAleese, J | 1 |
Descombey, D | 1 |
Forestier, F | 1 |
Rosenfeld, JA | 1 |
Meseguer, MA | 1 |
de Rafael, L | 1 |
Vidal, ML | 1 |
Scheibe, J | 1 |
Schulz, KR | 1 |
Kupferschmidt, HG | 1 |
Cheron, G | 1 |
Saint-Raymond, A | 1 |
Castot, A | 1 |
Kocher, R | 1 |
Haensch, G | 1 |
Fuchs, F | 1 |
Kimball, AC | 1 |
Kean, BH | 1 |
Sanz Martin, F | 1 |
Beverley, JK | 1 |
Stagno, S | 1 |
Reynolds, DW | 1 |
Shahin, B | 1 |
Papadopoulou, ZL | 1 |
Jenis, EH | 1 |
Carollo, F | 1 |
Spanó, C | 1 |
Dardanoni, L | 1 |
Markus, MB | 1 |
Kupka, S | 2 |
Vojtová, O | 1 |
Vedrová, D | 1 |
Poindexter, HA | 1 |
Doutlik, S | 1 |
Tolentino, P | 1 |
Hogan, MJ | 2 |
Siim, JC | 1 |
Leone, G | 1 |
Giza, T | 1 |
Hanicka, M | 1 |
Iygiste, AK | 1 |
Zasukhin, DN | 1 |
den Hartog Jager, WA | 1 |
Zigas, V | 1 |
Benfante, RJ | 1 |
Krogstad, DJ | 1 |
Juranek, DD | 1 |
Walls, KW | 1 |
Krüger, E | 1 |
Gerschke, G | 1 |
Fanghänel, M | 1 |
Meyfarth, G | 1 |
Molkentin, K | 1 |
Tonjum, A | 1 |
Lie, SO | 1 |
Boughton, CR | 1 |
Alexander, M | 1 |
Ming, AL | 1 |
Sedan, J | 1 |
Zabugin, FD | 1 |
Grossi-Bianchi, ML | 1 |
Pistone, FM | 1 |
Lässker, G | 1 |
Degen, R | 1 |
Keller, J | 1 |
Weissbach, G | 1 |
Geisler, E | 1 |
Osswald, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis[NCT02843438] | 72 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
28 reviews available for pyrimethamine and Congenital Infection, Toxoplasma gondii
Article | Year |
---|---|
Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Infectious Encephalitis; Pyrimethamine; Tox | 2017 |
Congenital toxoplasmosis.
Topics: Antibodies, Monoclonal; Antiparasitic Agents; Antiprotozoal Agents; Communicable Diseases; Genome, P | 2013 |
[Management of congenital toxoplasmosis in France: current data].
Topics: Antiprotozoal Agents; Coccidiostats; Female; France; Humans; Infant, Newborn; Infectious Disease Tra | 2010 |
Toxoplasma gondii: transmission, diagnosis and prevention.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Protozoan; Cats; Cattle; Deer; Encephalitis | 2002 |
[Toxoplasmosis].
Topics: Animals; Diagnosis, Differential; Female; Humans; Infant, Newborn; Molecular Diagnostic Techniques; | 2003 |
[Strategies for the diagnosis and treatment of prenatal toxoplasmosis - a survey].
Topics: Coccidiostats; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Pregnancy; Prenatal Diagn | 2004 |
Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?
Topics: Humans; Infant, Newborn; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Congenital | 2003 |
Preventive and therapeutic approaches to the newborn infant with perinatal viral and toxoplasma infections.
Topics: Antiviral Agents; Cytomegalovirus Infections; Herpes Simplex; Humans; Infant, Newborn; Infant, Newbo | 1981 |
Management of toxoplasmosis.
Topics: Anti-Infective Agents; Antiprotozoal Agents; Drug Synergism; Drug Therapy, Combination; Humans; Infa | 1994 |
Congenital infection with Toxoplasma gondii.
Topics: Clinical Trials as Topic; Female; Humans; Immunosorbent Techniques; Infant, Newborn; Mass Screening; | 1994 |
[Diagnosis and treatment of congenital toxoplasmosis].
Topics: Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Spira | 1993 |
Toxoplasmosis in pregnancy.
Topics: Animals; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethami | 1994 |
[Treatment of ocular toxoplasmosis. Part 1: Basic principles and diagnosis].
Topics: Clindamycin; Humans; Infant; Infant, Newborn; Pyrimethamine; Toxoplasmosis, Congenital; Toxoplasmosi | 1993 |
[Toxoplasmosis in pregnancy. Diagnosis and new therapeutic possibilities].
Topics: Adult; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Hemagglutination Tests; Hu | 1993 |
Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy.
Topics: Acute Disease; Antiprotozoal Agents; Female; Health Policy; Humans; Immunoglobulin G; Pregnancy; Pre | 1999 |
The child with congenital toxoplasmosis.
Topics: Child; Diagnosis, Differential; Eye Diseases; Female; Humans; Infant, Newborn; Infectious Disease Tr | 2000 |
[Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
Topics: Adult; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Child; Cocci | 2002 |
[Treatment of toxoplasmosis].
Topics: Humans; Immunotherapy; Pyrimethamine; Sulfones; Toxoplasmosis; Toxoplasmosis, Congenital | 1979 |
[Toxoplasmosis and pregnancy].
Topics: Drug Therapy, Combination; Female; Fetal Diseases; Germany, West; Humans; Infant, Newborn; Pregnancy | 1976 |
Toxoplasmosis.
Topics: Animals; Child; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Pregnancy; Pr | 1976 |
[Prevention and treatment of materno-fetal toxoplasmosis].
Topics: Adult; Female; Food Contamination; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Inf | 1991 |
[New viewpoints on the treatment of toxoplasmosis].
Topics: Age Factors; Child, Preschool; Demeclocycline; Female; Humans; Infant; Leucomycins; Pregnancy; Pyrim | 1973 |
[Toxoplasmosis].
Topics: Disease Reservoirs; Female; Humans; Infant, Newborn; Leucomycins; Pregnancy; Pyrimethamine; Sulfonam | 1972 |
Toxoplasmosis.
Topics: Animals; Antibodies; Cats; Clinical Laboratory Techniques; Disease Vectors; Humans; Immunity; Leucom | 1973 |
Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease.
Topics: Alabama; Central Nervous System Diseases; Cerebrospinal Fluid Proteins; Child, Preschool; Female; Hu | 1974 |
[Recent advances in the epidemiology, clinical aspects and therapy of toxoplasmosis].
Topics: Abortion, Habitual; Drug Synergism; Electroencephalography; Female; Humans; Infant, Newborn; Leucomy | 1970 |
Ocular toxoplasmosis.
Topics: Abortion, Spontaneous; Adult; Animals; Diagnosis, Differential; Eye Diseases; Female; Humans; Hypers | 1969 |
[Current status of research on the prevention of congenital toxoplasmosis].
Topics: Abortion, Spontaneous; Animals; Antibodies; Child, Preschool; Chlortetracycline; Complement Fixation | 1971 |
4 trials available for pyrimethamine and Congenital Infection, Toxoplasma gondii
Article | Year |
---|---|
Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Female; France; Humans; Infectious Disease T | 2018 |
Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.
Topics: Animals; Calcinosis; Chemistry, Pharmaceutical; Child; Child, Preschool; Drug Administration Schedul | 1994 |
[Clinical view of toxoplasmosis in children--personal observations].
Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combina | 1997 |
[In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
Topics: Drug Therapy, Combination; Female; Humans; Pregnancy; Pyrimethamine; Spiramycin; Sulfadiazine; Toxop | 1991 |
152 other studies available for pyrimethamine and Congenital Infection, Toxoplasma gondii
Article | Year |
---|---|
Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
Topics: Antiprotozoal Agents; Atovaquone; Brazil; Cell Line; Genetic Markers; Green Fluorescent Proteins; Hu | 2019 |
Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Disease Outbreaks; DNA, Protozoan; Drug Therapy, Combin | 2021 |
Report of an unsual case of anophthalmia and craniofacial cleft in a newborn with Toxoplasma gondii congenital infection.
Topics: Anophthalmos; Antiprotozoal Agents; Cytomegalovirus Infections; Female; Humans; Immunoglobulin G; Im | 2017 |
[DRESS complicated by hemophagocytic lymphohistiocytosis in an infant treated for congenital toxoplasmosis].
Topics: Antiprotozoal Agents; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Fatal Outcome; Hear | 2017 |
Use of polymerase chain reaction (PCR) in the diagnosis of congenital toxoplasmosis.
Topics: Antiprotozoal Agents; DNA, Protozoan; Drug Therapy, Combination; Early Diagnosis; Electroencephalogr | 2018 |
Congenital Toxoplasmosis in Tunisia: Prenatal and Neonatal Diagnosis and Postnatal Follow-up of 35 Cases.
Topics: Antiprotozoal Agents; Chorioretinitis; DNA, Protozoan; Drug Therapy, Combination; Female; Humans; Im | 2018 |
[Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia].
Topics: Adult; Drug Combinations; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical | 2018 |
Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Topics: Alcohol Dehydrogenase; Animals; Antiprotozoal Agents; Female; Genotype; Humans; Infant, Newborn; Mic | 2019 |
Toxoplasmosis and pregnancy.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Female; Humans; Infant, Newborn; Infectious Disease Tra | 2014 |
Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.
Topics: Adult; Anti-Infective Agents; Drug Combinations; Female; Humans; Infant, Newborn; Infectious Disease | 2015 |
Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
Topics: Antimalarials; Causality; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female | 2016 |
High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil.
Topics: Antiprotozoal Agents; Bone Marrow; Brazil; Child, Preschool; Female; Humans; Infant; Infant, Newborn | 2017 |
Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
Topics: Antimalarials; Drug Combinations; Drug Therapy, Combination; Humans; Pyrimethamine; Sulfadoxine; Tox | 2017 |
In Reply: Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
Topics: Antimalarials; Drug Combinations; Drug Therapy, Combination; Humans; Pyrimethamine; Sulfadoxine; Tox | 2017 |
Congenital Toxoplasmosis.
Topics: Antiprotozoal Agents; Brain; Calcinosis; Female; Humans; Infant; Leucovorin; Pyrimethamine; Sulfadia | 2017 |
Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis.
Topics: Antiprotozoal Agents; Clinical Protocols; Clinical Trials as Topic; Humans; Infant, Newborn; Pyrimet | 2009 |
Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis.
Topics: Amniocentesis; Animals; Antibodies, Protozoan; DNA, Protozoan; Drug Combinations; Enzyme-Linked Immu | 2009 |
Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Topics: Animals; Antibodies; Artemisia annua; Azithromycin; DNA, Protozoan; Drug Therapy, Combination; Embry | 2009 |
Delayed onset of severe neonatal toxoplasmosis.
Topics: Adolescent; Antiprotozoal Agents; Female; Heart Arrest; Humans; Infant, Newborn; Male; Pregnancy; Py | 2010 |
Congenital toxoplasmosis--a report on the Danish neonatal screening programme 1999-2007.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Denmark; Drug Administration S | 2010 |
Long-term outcome of children with congenital toxoplasmosis.
Topics: Age Factors; Child; Child Development; Child, Preschool; Chorioretinitis; Cohort Studies; Drug Combi | 2010 |
Choroidal neovascularization secondary to congenital toxoplasmosis in an infant.
Topics: Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Humans; Infant; Le | 2010 |
Unresolved questions about the most successful known parasite.
Topics: Animals; Child, Preschool; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertica | 2011 |
[Congenital toxoplasmosis following infection occurring late in pregnancy].
Topics: Adult; Antiprotozoal Agents; Child, Preschool; Drug Therapy, Combination; Early Diagnosis; Female; H | 2011 |
Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations.
Topics: Antiprotozoal Agents; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Fema | 2011 |
[Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?].
Topics: Antiprotozoal Agents; Drug Overdose; Humans; Infant, Newborn; Medication Errors; Prognosis; Pyrimeth | 2011 |
First case of congenital toxoplasmosis from Nepal.
Topics: Antimalarials; Antiprotozoal Agents; Drug Combinations; Fatal Outcome; Humans; Infant; Male; Nepal; | 2011 |
[Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches].
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Female; Germany; Humans; Male; Postnatal Car | 2012 |
Congenital toxoplasmosis in a neonate with significant neurologic manifestations.
Topics: Adult; Antibodies, Protozoan; Antiprotozoal Agents; Brain Diseases; Female; Fetal Growth Retardation | 2012 |
Birth prevalence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Brazil; Humans; Immunoglobulin M; Infant; Infant, Newbo | 2012 |
[Toxoplasma infections in early pregnancy: consequences and management].
Topics: Amniocentesis; Anti-Bacterial Agents; Antiprotozoal Agents; Female; Follow-Up Studies; Humans; Infan | 2002 |
[Toxoplasmosis in sick persons].
Topics: Abortion, Spontaneous; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Co | 2002 |
Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Chorioretinitis; Drug Therapy, Combination; Female; G | 2003 |
Congenital toxoplasmosis: therapeutic strategies.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; | 2003 |
Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier.
Topics: Adult; Animals; Antibodies, Protozoan; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; | 2003 |
Congenital toxoplasmosis with unusual retinal findings.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretinitis; DNA, Protozoan; Drug Therapy, | 2003 |
[OCULAR TOXOPLASMOSIS].
Topics: Atropine; Betamethasone; Clinical Laboratory Techniques; Epidemiology; Eye; Fetal Death; Humans; Mic | 1963 |
[PREVENTION AND THERAPY OF CONNATAL TOXOPLASMOSIS].
Topics: Communicable Diseases; Epidemiology; Female; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy C | 1963 |
[THE SYMPTOMS OF ACQUIRED AND CONGENITAL TOXOPLASMOSIS].
Topics: Central Nervous System Diseases; Eye Manifestations; Humans; Pyrimethamine; Toxoplasmosis; Toxoplasm | 1963 |
[TOXOPLASMOSIS, A NOTIFIABLE INFECTIOUS DISEASE].
Topics: Communicable Diseases; Diagnosis; Germany; Germany, West; Humans; Legislation, Medical; Pyrimethamin | 1964 |
[ON THE EPIDEMIOLOGY OF TOXOPLASMOSIS].
Topics: Animals; Communicable Diseases; Eggs; Epidemiology; Female; Humans; Infant; Infant, Newborn; Insect | 1964 |
[ON LYMPHADENOPATHIA TOXOPLASMOTICA].
Topics: Calcification, Physiologic; Humans; Lymph Nodes; Pyrimethamine; Radiography; Skull; Sulfanilamide; S | 1964 |
[2 CASES OF CONGENITAL TOXOPLASMOSIS].
Topics: Adrenal Cortex Hormones; Brain Diseases; Calcinosis; Child; Chlortetracycline; Drug Therapy; Erythro | 1964 |
TOXOPLASMA AND CHRONIC ABORTION.
Topics: Abortion, Induced; Female; Fetus; Humans; Infant; Infant Mortality; Pregnancy; Pyrimethamine; Sulfon | 1964 |
[ANIMAL EXPERIMENTAL STUDIES ON THE PROBLEM OF FETAL DAMAGE BY PYRIMETHAMINE].
Topics: Abnormalities, Drug-Induced; Animal Experimentation; Animals; Female; Fetal Diseases; Humans; Matern | 1964 |
THE TREATMENT OF GLANDULAR TOXOPLASMOSIS.
Topics: Child; Choroiditis; Drug Therapy; Female; Folic Acid; Humans; Lung Diseases; Lymphadenitis; Meningit | 1965 |
Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.
Topics: Adolescent; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Combinations; Female | 2004 |
[Congenital toxoplasmosis: a new case of infection during pregnancy in an previously immunized and immunocompetent woman].
Topics: Angola; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cesarean Section; Drug Therapy, Combin | 2004 |
[Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Pancytopenia; Parity; Pregna | 2004 |
Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
Topics: Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Infant; Infant, Newborn; Mass Spectro | 2005 |
Ocular manifestations in congenital toxoplasmosis.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Chorioretin | 2006 |
Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation.
Topics: Adult; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Female; Fetal Blood; HIV Infections; Hu | 2006 |
Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
Topics: Antiprotozoal Agents; Denmark; Drug Monitoring; Drug Therapy, Combination; Humans; Infant; Infant, N | 2006 |
[Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
Topics: Adolescent; Adult; Amniocentesis; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretini | 2005 |
[Prenatal treatment of congenital toxoplasmosis].
Topics: Antimalarials; Drug Combinations; Female; Follow-Up Studies; Humans; Leucovorin; Neutropenia; Pregna | 2005 |
Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres.
Topics: Adult; Anti-Bacterial Agents; Antiprotozoal Agents; Europe; Female; Gestational Age; Humans; Infant, | 2005 |
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
Topics: Antiprotozoal Agents; Chicago; Cognition; Drug Administration Schedule; Feasibility Studies; Humans; | 2006 |
Kinetic analysis of the humoral immune response against 3 Toxoplasma gondii-recombinant proteins in infants with suspected congenital toxoplasmosis.
Topics: Aging; Animals; Antibody Formation; Antigens, Protozoan; Antiprotozoal Agents; Gene Expression Regul | 2006 |
Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases.
Topics: Animals; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infectious Disease Tran | 2007 |
Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
Topics: Adolescent; Adult; Amniocentesis; Animals; Antimalarials; Antiprotozoal Agents; Biomarkers; Coccidio | 2007 |
[Study on the development of fetus and infant congenitally infected by Toxoplasma gondii and intervention].
Topics: Adult; Antiprotozoal Agents; Child Development; China; Female; Fetal Development; Follow-Up Studies; | 2007 |
Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis.
Topics: Animals; Anti-Infective Agents; Child, Preschool; Female; Humans; Immunoglobulin G; Immunoglobulin M | 2007 |
Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; | 2008 |
Cataracts in congenital toxoplasmosis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Cataract; Cataract Extraction; Child; Child, Preschool; Dru | 2007 |
Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.
Topics: Brain; Calcinosis; Choroiditis; Female; Humans; Infant; Infant, Newborn; Male; Multivariate Analysis | 2008 |
[Therapy of toxoplasmosis].
Topics: Humans; Pyrimethamine; Sulfonamides; Toxoplasmosis; Toxoplasmosis, Congenital; Yeast, Dried | 1967 |
[Congenital toxoplasmosis. Tolerability of the sulfadoxine-pyrimethamine combination. 24 cases].
Topics: Child, Preschool; Drug Combinations; Female; Humans; Infant; Leucovorin; Male; Pyrimethamine; Sulfad | 1984 |
[Toxoplasmosis and pregnancy. Prevention, early detection and therapy].
Topics: Austria; Drug Therapy, Combination; Female; Humans; Mass Screening; Pregnancy; Pregnancy Complicatio | 1983 |
[Treatment of congenital toxoplasmosis].
Topics: Antibodies; Child; Child, Preschool; Drug Therapy, Combination; Folic Acid; Humans; Infant; Leucomyc | 1983 |
[Congenital toxoplasmosis; observations on the recommendation of the Public Health Council].
Topics: Female; Humans; Infant, Newborn; Leucomycins; Pregnancy; Pregnancy Complications, Infectious; Pyrime | 1984 |
The diagnosis and treatment of toxoplasmosis.
Topics: Adult; Anti-Bacterial Agents; Antibodies; Antigens; Child; Female; Humans; Immunologic Deficiency Sy | 1983 |
[Toxoplasmosis].
Topics: Adult; Animals; Antibodies; Antimalarials; Drug Therapy, Combination; Female; Humans; Immunologic Te | 1980 |
[Difficulties in the diagnosis and treatment of toxoplasmosis].
Topics: Child; Child, Preschool; Clindamycin; Female; Humans; Infant; Infant, Newborn; Male; Pyrimethamine; | 1982 |
[Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Chorioretinitis; Drug Therapy, Combination; Follow-Up Studies; | 1980 |
[Congenital toxoplasmosis in two newborn infants (author's transl)].
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Pr | 1981 |
Late cerebral relapse of congenital toxoplasmosis.
Topics: Child; Chorioretinitis; Drug Therapy, Combination; Encephalitis; Female; Humans; Pyrimethamine; Recu | 1980 |
[Screening for toxoplasmosis in pregnancy--a pilot program in Northeast Germany].
Topics: Adult; Animals; Antibodies, Protozoan; Drug Therapy, Combination; Female; Germany; Humans; Infant, N | 1993 |
Neurologic and developmental outcome in treated congenital toxoplasmosis.
Topics: Child Development; Female; Humans; Hydrocephalus; Infant; Infant, Newborn; Intelligence; Longitudina | 1995 |
Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
Topics: Antibodies, Protozoan; Central Nervous System Diseases; Follow-Up Studies; Humans; Immunoglobulin G; | 1994 |
[Diagnosis and therapy of toxoplasmosis infections in pregnancy at the Rostock University Gynecologic Clinic 1986-1994].
Topics: Adult; Coccidiostats; Cross-Sectional Studies; Drug Therapy, Combination; Female; Germany; Gestation | 1995 |
Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis.
Topics: Anti-Infective Agents; Brain; Calcinosis; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leucov | 1996 |
Recurrent congenital toxoplasmosis in a woman with lupus erythematosus.
Topics: Adult; Amniotic Fluid; Animals; Anti-Infective Agents; Antibodies, Protozoan; Female; Fetal Diseases | 1995 |
Eye manifestations of congenital toxoplasmosis.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Drug Therapy, Combination; Female | 1996 |
[Congenital toxoplasmosis with hydrocephalus diagnosed in utero: outcome of treatment].
Topics: Anti-Infective Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrocephalus; | 1997 |
Eye manifestations of congenital toxoplasmosis.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Choroid Diseases; Cicatrix; Femal | 1997 |
Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
Topics: Anti-Infective Agents; Coccidiostats; Drug Administration Schedule; Drug Therapy, Combination; Femal | 1998 |
Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
Topics: Anti-Infective Agents; Antiprotozoal Agents; Female; Fetal Diseases; Humans; Pregnancy; Pyrimethamin | 1998 |
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Chorioretinitis; Drug Administration Schedule; D | 1998 |
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Brain Diseases; Calcinosis; Choroid Diseases; | 1999 |
Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid.
Topics: Adult; Amniotic Fluid; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; DNA, Protozoan; Drug Th | 1998 |
Congenital toxoplasmosis: prenatal diagnosis, treatment and postnatal outcome.
Topics: Adult; Amniocentesis; Animals; Antiprotozoal Agents; Cordocentesis; DNA, Protozoan; Echoencephalogra | 1999 |
Congenital toxoplasmosis, later relapses and treatment.
Topics: Adult; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Child; Female; Follow-Up Studies; Human | 1999 |
[Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
Topics: Adult; Antibodies, Protozoan; Antiprotozoal Agents; Female; Humans; Immunoglobulin A; Immunoglobulin | 1999 |
Serologic rebounds after one-year-long treatment for congenital toxoplasmosis.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Drug Administration Schedule; Drug Therapy, Combination | 2000 |
[Analysis of a case of severe congenital toxoplasmosis].
Topics: Acute Disease; Administration, Topical; Adult; Animals; Anti-Inflammatory Agents; Antibodies, Protoz | 1999 |
Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cohort Studies; Female; Fetal Blood; Fetal Dis | 2001 |
[Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases].
Topics: Age Factors; Analysis of Variance; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; | 2002 |
[Frequency of persistent or transitory serologic negative values in infants with congenital toxoplasmosis. Experience of the Reims Toxoplasmosis Group (1980-1997)].
Topics: Animals; Antibodies, Protozoan; Drug Combinations; Follow-Up Studies; Humans; Infant; Infant, Newbor | 2002 |
[Lymphadenitis caused by toxoplasmosis during gravidity -- an aetiological factor in congenital damage to the child (author's transl)].
Topics: Anti-Bacterial Agents; Female; Humans; Hydrocephalus; Infant, Newborn; Lymphadenitis; Male; Pregnanc | 1979 |
[The significance of toxoplasmosis in pregnancy].
Topics: Abortion, Spontaneous; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectio | 1977 |
[Letter: Significance of Toxoplasma infections for public health].
Topics: Eye Manifestations; Humans; Immunoglobulin M; Infant, Newborn; Leucomycins; Pyrimethamine; Sulfadiaz | 1975 |
[Toxoplasmosis. Clinical characteristics and treatment (author's transl)].
Topics: Female; Humans; Infant, Newborn; Pregnancy; Pyrimethamine; Serologic Tests; Sulfonamides; Toxoplasmo | 1975 |
Screening for toxoplasmosis in pregnant women: presentation of a screening programme in the former "East"-Germany, and the present status in Germany.
Topics: Drug Therapy, Combination; Female; Germany; Germany, East; Humans; Incidence; Infant, Newborn; Mass | 1992 |
[Congenital toxoplasmosis in the Alpes-Maritimes region. Apropos of 26 cases observed between 1984 and 1990].
Topics: Child; Child, Preschool; Drug Combinations; Follow-Up Studies; France; Humans; Infant; Pyrimethamine | 1992 |
Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group.
Topics: Chromatography, High Pressure Liquid; Humans; Infant; Infant, Newborn; Leucovorin; Phenobarbital; Py | 1992 |
IgM ELISA follow-up of spiramycin treatment for toxoplasmosis: should the drug be prescribed in India?
Topics: Adult; Animals; Antibodies, Protozoan; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglob | 1992 |
Difficulties in the diagnosis of congenital toxoplasmosis by cordocentesis. Case report.
Topics: Acute Disease; Adult; Animals; Antibodies, Protozoan; Drug Therapy, Combination; Female; Fetal Blood | 1991 |
[Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Pregnancy; Prenatal Care; Pyrimet | 1990 |
Phenotypes and functions of lymphocytes in congenital toxoplasmosis.
Topics: Adult; Animals; Antigens, Protozoan; Child, Preschool; Concanavalin A; Humans; Infant; Interferon-ga | 1990 |
[Prevention of congenital toxoplasmosis].
Topics: Adult; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Prenatal Dia | 1990 |
Treatment of congenital toxoplasmosis.
Topics: Adrenal Cortex Hormones; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Pyrimethamine; | 1990 |
Treatment of congenital toxoplasmosis during pregnancy.
Topics: Female; Fetal Diseases; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; P | 1990 |
Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.
Topics: Acquired Immunodeficiency Syndrome; Animals; Central Nervous System Diseases; Family Health; Female; | 1990 |
Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.
Topics: Female; Follow-Up Studies; Humans; Infant, Newborn; Predictive Value of Tests; Pregnancy; Pregnancy | 1989 |
New perspectives in the chemoprophylaxis of toxoplasmosis.
Topics: Chorioretinitis; Drug Combinations; Female; Fetal Diseases; Humans; Immune Tolerance; Infant, Newbor | 1989 |
Maternal and congenital toxoplasmosis. Is prevention possible?
Topics: Amniocentesis; Female; Fetal Blood; Fetal Diseases; Humans; Pregnancy; Prenatal Diagnosis; Pyrimetha | 1988 |
Stevens-Johnson syndrome with isolation of Mycoplasma pneumoniae from skin lesions.
Topics: Humans; Infant; Male; Mycoplasma pneumoniae; Pyrimethamine; Pyrithioxin; Skin; Stevens-Johnson Syndr | 1986 |
[Clinical aspects of Toxoplasma primary infection in pregnancy].
Topics: Animals; Antibodies, Protozoan; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyri | 1988 |
[Congenital toxoplasmosis, convulsions and overdose of pyrimethamine].
Topics: Female; Humans; Infant, Newborn; Pyrimethamine; Seizures; Toxoplasmosis, Congenital | 1987 |
Toxoplasmosis in pregnancy and its transmission to the fetus.
Topics: Adolescent; Adult; Female; Gestational Age; Humans; Infant; Infant, Newborn; Leucomycins; Maternal-F | 1974 |
The management of toxoplasmosis in pregnancy.
Topics: Abortion, Spontaneous; Abortion, Therapeutic; Female; Humans; Infant; Infant, Newborn; Leucovorin; P | 1974 |
Congenital nephrotic syndrome associated with congenital toxoplasmosis.
Topics: Antigen-Antibody Complex; Blood Proteins; Cholesterol; Edema; Fluorescent Antibody Technique; Furose | 1974 |
[Considerations on some cases of repeated abortions probabily due to Toxoplasma gondii (author's transl)].
Topics: Abortion, Habitual; Adult; Antibody Formation; Drug Therapy, Combination; Female; Folic Acid; Humans | 1972 |
Symptoms, transmission, prevention and treatment of toxoplasmosis.
Topics: Adult; Animals; Cat Diseases; Cats; Child; Dogs; Female; Humans; Infant; Infant, Newborn; Lymph Node | 1973 |
[Regular supervision of pregnant women for the prevention of congenital toxoplasmosis].
Topics: Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyri | 1973 |
[The problems of congenital ocular toxoplasmosis (author's transl)].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Leucomycins; Ma | 1973 |
Toxoplasmosis.
Topics: BCG Vaccine; Female; Humans; Infant, Newborn; Leucomycins; Pregnancy; Pregnancy Complications, Infec | 1973 |
Congenital toxoplasmosis. A prospective study of 378 pregnancies.
Topics: Antibodies; Female; Humans; Infant, Newborn; Leucomycins; Methods; Paris; Placenta; Pregnancy; Pregn | 1974 |
[The neurologic manifestations of toxoplasmosis].
Topics: Adolescent; Adult; Brain Diseases; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; | 1974 |
[Acquired toxoplasmosis].
Topics: Adult; Animals; Child; Diagnosis, Differential; Female; Humans; Lymphadenitis; Mice; Pregnancy; Pyri | 1971 |
[Diagnosis and prevention of toxoplasmosis].
Topics: Animals; Anti-Bacterial Agents; Antibody Formation; Antigens; Complement System Proteins; Female; Fl | 1971 |
[Toxoplasmosis].
Topics: Adult; Brain; Calcinosis; Chorioretinitis; Demeclocycline; Encephalomyelitis; Female; Humans; Hydroc | 1969 |
[Importance of decalcification in the treatment of toxoplasmosis].
Topics: Adolescent; Calcium; Child; Child, Preschool; Edetic Acid; Female; Humans; Male; Pyrimethamine; Sulf | 1971 |
[Aqueduct stenosis and toxoplasmosis].
Topics: Adolescent; Adult; Child; Drainage; Echoencephalography; Female; Humans; Hydrocephalus; Infant, Newb | 1972 |
[Teratogenicity of daraprim (pyrimethamine) in man].
Topics: Abnormalities, Drug-Induced; Adult; Female; Gestational Age; Humans; Pregnancy; Pregnancy Complicati | 1972 |
Human toxoplasmosis: an evaluation of current progress.
Topics: Animals; Antibodies; Cats; Climate; Disease Reservoirs; Dogs; Female; Humans; Infant, Newborn; Pregn | 1972 |
Toxoplasmosis. With comments on risk of infection from cats.
Topics: Animals; Cat Diseases; Cats; Feces; Female; Food Contamination; Humans; Male; Meat; Pregnancy; Pregn | 1972 |
[Ocular toxoplasmosis].
Topics: Diagnosis, Differential; Eye; Female; Humans; Leucovorin; Prednisone; Pregnancy; Pregnancy Complicat | 1968 |
[Stages in the prophylaxis of toxoplasmosis].
Topics: Adult; Bone Marrow; Bone Marrow Diseases; Female; Humans; Leucovorin; Pregnancy; Pregnancy Complicat | 1970 |
[Adverse effects of combined toxoplasmosis therapy with daraprim and sulfonamides].
Topics: Humans; Infant, Newborn; Pyrimethamine; Sulfonamides; Toxoplasmosis, Congenital | 1969 |
[Congenital toxoplasmosis diagnosis, a cooperative effort of obstetrician and pediatrician].
Topics: Adult; Encephalitis; Female; Humans; Infant, Newborn; Pregnancy; Pyrimethamine; Serologic Tests; Ski | 1969 |
[Congenital toxoplasmosis].
Topics: Age Factors; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Pyrimethamine; | 1970 |
Toxoplasmosis.
Topics: Communicable Diseases; Complement Fixation Tests; Female; Hemagglutination Tests; Humans; Infant, Ne | 1970 |
[Epidemiology, clinical aspects and therapy of toxoplasmosis].
Topics: Administration, Oral; Adult; Animals; Child; Complement Fixation Tests; Diagnosis, Differential; Fem | 1970 |
Adult ocular manifestation of congenital toxoplasmosis.
Topics: Adult; Female; Humans; Male; Pyrimethamine; Sulfamethazine; Toxoplasmosis, Congenital; Toxoplasmosis | 1967 |
[Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
Topics: Folic Acid; Humans; Leucomycins; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Congenital; Toxoplasmos | 1967 |
[Various data on the treatment of toxoplasmosis with chloridin].
Topics: Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfamethazine; Toxop | 1968 |
Toxoplasmosis.
Topics: Bone Marrow Diseases; Female; Glucocorticoids; Hematopoiesis; Humans; Pregnancy; Pyrimethamine; Sulf | 1968 |
[Hypsarrhythmic syndrome caused by congenital toxoplasmosis cured with pyrimethamine].
Topics: Electroencephalography; Female; Humans; Infant; Pyrimethamine; Spasm; Spasms, Infantile; Toxoplasmos | 1968 |
[The significance of the results of serological tests carried out during pregnancy for the prevention and diagnosis of congenital toxoplasmosis].
Topics: Adult; Animals; Female; Humans; Infant; Infant, Newborn; Pregnancy; Pyrimethamine; Serologic Tests; | 1969 |
[Effects of combined treatment of infantile toxoplasmosis with pyrimethamine (daraprim) and sulfonamides on the blood and bone marrow].
Topics: Agranulocytosis; Anemia, Macrocytic; Drug Synergism; Folic Acid Antagonists; Humans; Infant; Infant, | 1965 |
[Toxoplasmosis in childhood. Clinical findings and conclusions for medical practice].
Topics: Female; Humans; Infant; Infant, Newborn; Male; Pyrimethamine; Serologic Tests; Sulfonamides; Toxopla | 1965 |